Your shopping cart is currently empty

MS-177 is a PROTAC EZH2 degrader that promotes cholangiocarcinoma growth through the EZH2-mediated WNT7B/β-catenin pathway.MS-177 inhibits the growth of leukemia cells, induces apoptosis, and cell cycle arrest.MS-177 induces degradation of the classical EZH2-PRC2 and the non-classical EZH2-cMyc complexes and activates the immune-responsive genes in MM cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $81 | 8-10 weeks | 8-10 weeks | |
| 5 mg | $197 | 8-10 weeks | 8-10 weeks | |
| 10 mg | $313 | 8-10 weeks | 8-10 weeks | |
| 25 mg | $619 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $993 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $1,490 | 8-10 weeks | 8-10 weeks | |
| 1 mL x 10 mM (in DMSO) | $397 | 8-10 weeks | 8-10 weeks |
| Description | MS-177 is a PROTAC EZH2 degrader that promotes cholangiocarcinoma growth through the EZH2-mediated WNT7B/β-catenin pathway.MS-177 inhibits the growth of leukemia cells, induces apoptosis, and cell cycle arrest.MS-177 induces degradation of the classical EZH2-PRC2 and the non-classical EZH2-cMyc complexes and activates the immune-responsive genes in MM cells. |
| Targets&IC50 | EOL-1 cells:82% (Dmax), MV-4-11 cells:68% (Dmax), MV-4-11 cells:1.5 µM, EZH2 (PRC2):7 nM, EOL-1 cells:0.2 µM (DC50) |
| In vitro | MS-177 inhibits the enzymatic activities of EZH2-PRC2 (IC50=7 nM). In EOL-1 and MV4;11 cells, MS-177 exhibited half-maximal degradation concentration (DC50) values of 0.2 µM and 1.5 µM, and maximum degradation (Dmax) values of 82% and 68%. [1] |
| In vivo | Two doses of MS-177 (100 mg/kg intraperitoneally twice a day, 6 days per week; and 200 mg/kg intraperitoneally twice a day, 3 days per week) were well tolerated in mice and showed no significant toxicity. The antitumor effects of MS-177 were evaluated using a patient-derived xenograft (PDX) animal model of MLL-r AML, and both of the above MS-177 dosing regimens significantly inhibited AML growth in the PDX model, either established by seeding or subcutaneous inoculation, and prolonged survival, relative to controls. [1] |
| Synonyms | MS177 |
| Molecular Weight | 914.02 |
| Formula | C48H55N11O8 |
| Cas No. | 2225938-86-1 |
| Smiles | O=C(NCC=1C(=O)NC(=CC1C)C)C2=CC(=CC3=C2C=NN3C(C)C)C=4C=NC(=CC4)N5CCN(CCNC(=O)CCOCCNC6=CC=CC=7C(=O)N(C(=O)C67)C8C(=O)NC(=O)CC8)CC5 |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 120 mg/mL(131.29 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.